Impact of N-Acetylcysteine on Oxidative Stress and Renal Function in Deceased Kidney Transplant Recipients
NCT ID: NCT00851708
Last Updated: 2009-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protective Effect of N-acetylcysteine on Early Outcomes of Deceased Renal Transplant
NCT00994305
N-acetylcysteine to Prevent Renal Failure
NCT01359722
Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery
NCT00211653
Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.
NCT00190034
Acute Renal Failure Post Liver Transplantation
NCT01907061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NAC
treatment
N-acetylcysteine
600 mg bid orally from day 1 to 7 postoperative
control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
N-acetylcysteine
600 mg bid orally from day 1 to 7 postoperative
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Deceased kidney transplant
Exclusion Criteria
* illicit drug addiction
* psychiatric disorders
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundação de Amparo à Pesquisa do Estado de São Paulo
OTHER_GOV
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinics Hospital, University of Sao Paulo, Medical School
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAPESP 06/52046-0
Identifier Type: -
Identifier Source: secondary_id
NAC vs DKT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.